Showing 1261-1270 of 8663 results for "".
Can UV Nail Dryers Cause Skin Cancer?
https://practicaldermatology.com/topics/hair-nails/can-uv-nail-dryers-cause-skin-cancer/23898/Alexis Livingston Young, MD, weighs in on the evidence.Dermal Micro-Coring 101
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dermal-micro-coring-101/23376/Expert insight on a new energy-free facelift alternative.Can Dupilumab Improve Keloid Scarring?
https://practicaldermatology.com/topics/skin-of-color/can-dupilumab-improve-keloid-scarring/23820/Bimekizumab-bkzx Journal Scan: 4 Clinical Trials
https://practicaldermatology.com/topics/digital-supplement/bimekizumab-bkzx-journal-scan-4-clinical-trials/24128/Speed, depth, and durability from the first dual IL-17A/F inhibitor for the treatment of moderate to severe plaque psoriasis.Driving Practice Value in a Sale or Capital Raise: The Sellside Quality of Earnings Report
https://practicaldermatology.com/topics/practice-management/driving-practice-value-in-a-sale-or-capital-raise-the-sellside-quality-of-earnings-report/23991/Be strong in your numbers, because buyers will be looking.Take 5 With Peter Kang, CEO, CoolHealth
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/take-5-with-peter-kang-ceo-coolhealth-1/23926/What’s New in Nonmelanoma Skin Cancer Treatment?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/whats-new-in-nonmelanoma-skin-cancer-treatment/23895/Recent research explores a growing range of nonsurgical options.Currents: Dermatology Comes of Age
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/currents-dermatology-comes-of-age/23879/Meet the CSF Faculty
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/meet-the-csf-faculty/23824/Get to know Dr. Todd SchlesingerIn the Pipeline: New Approaches to Vitiligo, Congenital Ichthyosis, and More
https://practicaldermatology.com/topics/pigmentary-disorders/in-the-pipeline-new-approaches-to-vitiligo-congenital-ichthyosis-and-more/23714/Inflammatory diseases with few or no specific treatments may soon have approved interventions.